ATI RN
Immune System Drugs Questions
Question 1 of 5
The nurse is preparing to administer varicella vaccine to a young woman. Which of the following findings has the greatest implication for this young woman's care?
Correct Answer: D
Rationale: The correct answer is D because administering varicella vaccine to a pregnant woman can pose serious risks to the fetus, including birth defects. This finding has the greatest implication for care as it involves the safety and well-being of both the woman and the unborn child. A: Fear of needles is a common issue that can be managed with appropriate support and techniques. B: Allergy to eggs is a contraindication for receiving the varicella vaccine, but alternative vaccines can be considered. C: Past history of leukemia as a child may affect the immune response to the vaccine, but it is not as critical as pregnancy in this scenario.
Question 2 of 5
Which of the following patients would be eligible to receive the influenza vaccine?
Correct Answer: B
Rationale: The correct answer is B, the pregnant patient. Pregnant individuals are recommended to receive the influenza vaccine to protect both themselves and their unborn child. Pregnant women are at higher risk of complications from the flu. Choice A is incorrect because caregivers of immunocompromised individuals are not in the high-risk group for influenza. Choice C is incorrect because there are egg-free influenza vaccine options available for patients with egg allergies. Choice D is incorrect because the influenza vaccine is not recommended for children under 6 months, and 18 months old is below the recommended age for vaccination.
Question 3 of 5
The health care provider plans to inject an interferon directly into the patient's wart. What interferon will the nurse prepare?
Correct Answer: C
Rationale: Rationale: The correct answer is C: Interferon alfa n3 (Alferon N). Alferon N is specifically approved for treating viral warts. Interferon alfa 2a (A) is used for chronic hepatitis B/C. Interferon alfacon 1 (B) is for hepatitis C. Interferon beta 1a (D) is for multiple sclerosis. Alferon N is the most appropriate choice for wart treatment.
Question 4 of 5
The nurse has an order to administer oprelvekin (Neumega) to a patient for the first time. Before administering the drug, what allergy would the nurse want to specifically question the patient about?
Correct Answer: B
Rationale: The correct answer is B: Escherichia coli-produced products. Oprelvekin is a recombinant human interleukin-11 produced in Escherichia coli bacteria. Therefore, the nurse should specifically question the patient about any allergies to Escherichia coli-produced products before administering the drug. A: Egg products - Not relevant to oprelvekin. C: Lactose intolerance - Not relevant to oprelvekin. D: Penicillin - Not relevant to oprelvekin.
Question 5 of 5
A patient who is receiving an immune suppressant has been admitted to the unit. What would be a priority action by the nurse?
Correct Answer: C
Rationale: The correct answer is C because protecting the patient from exposure to infection is a priority for a patient receiving immune suppressants. Immune suppressants weaken the body's immune system, making the patient more vulnerable to infections. This action helps prevent complications and promotes patient safety. Monitoring nutritional status (A) is important but not as urgent as preventing infections. Providing patient teaching (B) and support for adverse effects (D) are important but secondary to preventing infections in a patient on immune suppressants.